RARγ is an oncogene for many different cancers, including acute myeloid leukaemia and cholangiocarcinoma, and colorectal, head and neck, hepatocellular, ovarian, pancreatic, prostate, and renal cancers. This evidence concerns the gene RARG and cholangiocarcinoma.